MedPath

Curium PET France

Curium PET France logo
🇫🇷France
Ownership
Holding
Established
2000-01-01
Employees
51
Market Cap
-
Website
http://www.cyclopharma.fr/en

Clinical Trials

4

Active:2
Completed:1

Trial Phases

2 Phases

Phase 1:2
Phase 3:2

Drug Approvals

4

EMA:2
CIMA_AEMPS:2

Drug Approvals

Pylclari

Authorization Status
Authorised
Approval Date
Nov 27, 2023
EMA

Pylclari

Authorization Status
Authorised
Approval Date
Nov 27, 2023
EMA

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 3
2 (50.0%)

A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer

Phase 3
Conditions
Prostate Cancer Recurrent
First Posted Date
2021-02-02
Last Posted Date
2021-02-02
Lead Sponsor
Curium PET France
Target Recruit Count
217
Registration Number
NCT04734184
Locations
🇫🇷

CURIUM PET France, Saint-Beauzire, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.